Effet paradoxal des anti-TNF : un cas unique de sarcoïdose systémique réfractaire aggravée par infliximab
S. Lechtman(Délégation Paris 7), D. Sène(Assistance Publique – Hôpitaux de Paris), Célia Lloret‐Linares(Hôpital Lariboisière), K. Champion(Hôpital Lariboisière), Jean‐François Bergmann(Northern General Hospital), Stéphane Mouly(Délégation Paris 7), Mélanie Roriz(Hôpital Lariboisière), Inmaculada Jarrín(Instituto de Salud Carlos III)
Cited by 0
Related Papers
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
|Science Immunology|2021|638
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
|The Lancet Infectious Diseases|2017|587
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
|Proceedings of the National Academy of Sciences|2022|198